This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV‐infected infants and toddlers, British Journal of Clinical Pharmacology, March 2012, Wiley,
DOI: 10.1111/j.1365-2125.2011.04121.x.
You can read the full text:
The following have contributed to this page
